1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. JOHNSON & JOHNSON
Johnson & Johnson XNYS: JNJ

Johnson & Johnson Live Stock Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After...

Read More
204.39 -1.36 (-0.66%)
44.45% Gain from 52W Low
6.2M
XNYS Volume

XNYS 09 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Tariff Relief
J&J finalizes deal with the US government to lower drug prices in exchange for tariff exemption See details
Durability score
High Financial Strength
55.6 / 100
Valuation Score
Mid Valuation
44.8 / 100
Momentum Score
Technically Moderately Bullish
63.1 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM
Analyst Price Target
212
1Yr Price target upside is 4%
24 analysts

8

S

7

W

6

O

0

T

SWOT Analysis

Johnson & Johnson Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..